ATC kod: D02AE01, D02AE51, D07XA01
Det saknas kontrollerade studier om skillnader mellan könen avseende effekt, säkerhet och farmakokinetik för karbamid.
The main indication of carbamide preparations is moisturizing treatment of dry skin [2].
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of carbamide have been found.
No studies with a clinically relevant sex analysis regarding the effect of carbamide have been found.
No studies with a clinically relevant sex analysis regarding adverse effects of carbamide have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
A retrospective analysis of patients with eczema or psoriasis on standard dermatological treatment (295 men, 291 women) found that significantly more men than women (79; 63%, 47; 37%) were administered whole-body UV treatment. Also, the results indicated that men had more treatments appointments per individual than women. Women were prescribed more emollients than men [1].
Fler kvinnor än män hämtade ut karbamid (ATC-kod D02AE01) på recept i Sverige år 2019, totalt 161 704 kvinnor och 122 561 män. Det motsvarar 32 respektive 24 patienter per tusen invånare. Andelen som hämtat ut läkemedlet ökade med stigande ålder hos båda könen. I genomsnitt var karbamid 1,3 gånger vanligare hos kvinnor [3].
Uppdaterat: 2020-10-06
Litteratursökningsdatum: 2020-04-17
Faktagranskat av: Diana Rydberg, Carl-Olav Stiller
Godkänt av: Karin Schenck-Gustafsson